Nerve Monitoring Devices for Spinal Fusion Surgery
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the differences (the effectiveness and the safety) between two different nerve and muscle monitoring devices currently available during a TLIF surgery. The Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and Retractor surgical and nerve monitoring tools will be used in addition to standard nerve monitoring tools during the surgery. The choice of standard nerve monitoring equipment is based on the decision of the surgeon and technologist and is not dictated by this study. These tools will be compared with regards to safety and ability to accurately monitor the nervous system during the surgery.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are currently undergoing treatment with chemotherapy, radiation, or immunosuppression, you would not be eligible to participate.
What data supports the effectiveness of the treatment Nerve Cuff and Retractor System for spinal fusion surgery?
The research on nerve monitoring devices, such as the newly designed nerve monitor and the cuff electrode for reversible conduction blocking, suggests that these technologies can safely and reliably monitor nerve health during surgery. This implies that similar devices, like the Nerve Cuff and Retractor System, may also be effective in ensuring nerve safety during spinal fusion surgery.12345
Is the Nerve Monitoring Device for Spinal Fusion Surgery safe for humans?
How is the Nerve Cuff and Retractor System treatment for spinal fusion surgery different from other treatments?
The Nerve Cuff and Retractor System is unique because it combines nerve monitoring with a retractor system, allowing for continuous and real-time monitoring of nerve activity during spinal fusion surgery. This helps prevent nerve damage by providing immediate feedback to the surgeon, which is not typically available with standard surgical tools.3781011
Research Team
Nicholas Poulos, MD
Principal Investigator
Retropsoas Technologies, LLC
Eligibility Criteria
This trial is for individuals undergoing a single or two-level TLIF spinal fusion surgery between L2-S1. It's not suitable for those with more than two levels of lumbar interbody fusion needed, only L5-S1 level surgery, acute trauma, previous relevant surgeries, BMI over 40, smokers, certain muscle weakness or vascular diseases, allergies to anesthesia or materials used in the cuff and retractor system.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo TLIF surgery with monitoring using the EARP Nerve Cuff Electrode and Retractor system
Follow-up
Participants are monitored for safety and effectiveness after surgery
Treatment Details
Interventions
- Nerve Cuff and Retractor System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Retropsoas Technologies, LLC
Lead Sponsor